SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Silence Therapeutics Q3 net loss narrows 41% to $12.43 million

Silence Therapeutics Q3 net loss narrows 41% to $12.43 million Silence Therapeutics’ third-quart

SLNCF

Related stories